The silencing of the Arp2/3 complex subunits typically reduces the cell migration capacity in pancreatic cancer, bladder cancer, and head and neck squamous cell carcinoma (Kinoshita et al., 2012; Rauhala et al., 2013; Xu et al., 2020). Here, ACTR2 is linked to head and neck squamous cell carcinoma.